U.S. Markets closed

Societal CDMO, Inc. (SCTL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.7000-0.0300 (-1.73%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.7300
Bid1.6900 x 1000
Ask1.8500 x 800
Day's Range1.5200 - 1.7050
52 Week Range0.6200 - 2.1900
Avg. Volume60,063
Market CapN/A
Beta (5Y Monthly)0.67
PE Ratio (TTM)N/A
Earnings DateFeb 27, 2023 - Mar 03, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.04
  • Zacks Small Cap Research

    SCTL: New Business Trends Illustrate Strong Momentum

    By M. Marin NASDAQ:SCTL READ THE FULL SCTL RESEARCH REPORT Company believes it is outperforming on new business wins Societal CDMO’s (NASDAQ:SCTL) strategy to garner a growing share of the CDMO market appears to be gaining traction, as illustrated by new business trends. Societal, an established small-molecule CDMO (contract development and manufacturing organization), is positioning itself as an

  • GlobeNewswire

    Cingulate Inc. Reports Third Quarter 2022 Financial Results and Provides Clinical and Business Update

    Consolidated Balance Sheet Data Consolidated Balance Sheet Data Consolidated Statement of Operations Consolidated Statement of Operations Phase 3 Trial Initiation for Lead ADHD Candidate CTx-1301 in December 2022 Executed Manufacturing Agreement with Societal CDMO 2022 Psych Congress Presentation Demonstrated Ability of Anxiety Candidate CTx-2103 to Deliver a Single Administration of Triple-Release Buspirone KANSAS CITY, Kan., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a bi

  • Simply Wall St.

    Societal CDMO Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag

    Societal CDMO ( NASDAQ:SCTL ) Third Quarter 2022 Results Key Financial Results Revenue: US$21.6m (up 18% from 3Q 2021...